CAMBRIDGE, Mass.--(BUSINESS WIRE)--Parallel Bio, a biotech company pioneering human-first drug discovery, today announced it has raised $21 million Series A funding, led by AIX Ventures. The round ...

NEW YORK--(BUSINESS WIRE)--Parallel Learning (Parallel)—the digital health platform that provides a new way to test, diagnose, and empower students with learning and thinking differences—today ...